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Although it is well established that the WAVE/SCAR complex transduces Rac1 signaling to trigger Arp2/3-dependent actin nucleation,
regulatory mechanisms of this complex and its versatile function in the nervous system are poorly understood. Here we show that the
Drosophila proteins SCAR, CYFIP and Kette, orthologs of WAVE/SCAR complex components, all show strong accumulation in axons of
the central nervous system and indeed form a complex in vivo. Neuronal defects of SCAR, CYFIP and Kette mutants are, despite the initially
proposed function of CYFIP and Kette as SCAR silencers, indistinguishable and are as diverse as ectopic midline crossing and nerve
branching as well as synapse undergrowth at the larval neuromuscular junction. The common phenotypes of the single mutants are readily
explained by the finding that loss of any one of the three proteins leads to degradation of its partners. As a consequence, each mutant is
unambiguously to be judged as defective in multiple components of the complex even though each component affects different signaling
pathways. Indeed, SCAR-Arp2/3 signaling is known to control axonogenesis whereas CYFIP signaling to the Fragile X Mental Retardation
Protein fly ortholog contributes to synapse morphology. Thus, our results identify the Drosophila WAVE/SCAR complex as a
multifunctional unit orchestrating different pathways and aspects of neuronal connectivity.
D 2004 Elsevier Inc. All rights reserved.
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Innocenti et al., 2004), which directs actin cytoskeleton
remodeling (Pollard and Beltzner, 2002). Mechanisms of
WAVE/SCAR complex signal transduction and consequen-
ces of its manipulation in different cellular systems have
been recently under debate (Blagg et al., 2003; Bogdan
and Klambt, 2003; Eden et al., 2002; Gautreau et al.,
2004; Innocenti et al., 2004; Kunda et al., 2003; Rogers et
al., 2003; Steffen et al., 2004) (for an overview, see Blagg
and Insall, 2004). Whereas it is unquestionable that the
WAVE/SCAR protein can bind and activate the Arp2/3
complex, dissenting views exist about the mechanisms274 (2004) 260–270
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the four WAVE/SCAR-associated proteins have been
thought to inhibit WAVE/SCAR activity until they
dissociate from the protein upon Rac1 signaling (Eden et
al., 2002). Since these pioneer in vitro data, some cellular
studies have presented data supporting such a negative
regulation (Blagg et al., 2003; Bogdan and Klambt, 2003),
whereas others have shown that WAVE/SCAR protein
activity is positively regulated by its associated proteins
(Innocenti et al., 2004). Furthermore, the four proteins
have been implicated in control of localisation and stability
of the WAVE/SCAR protein (Blagg et al., 2003; Innocenti
et al., 2004; Kunda et al., 2003; Rogers et al., 2003;
Steffen et al., 2004). Despite these mechanistic discrep-
ancies, such studies clearly highlight the importance of the
associated proteins as WAVE/SCAR regulators.
In the present study, we have addressed the role of the
WAVE/SCAR complex in development of the nervous
system, an issue that is of major importance, given the
instructive role of Rac1 signaling pathways in neuronal
actin remodeling underlying axon as well as synapse
development (reviewed in Luo, 2002). Furthermore, muta-
tions of several genes directly affecting Rho/Rac regulatory
or effector proteins cause hereditary cases of mental
retardation (reviewed in Chelly and Mandel, 2001; Rama-
kers, 2002), strongly emphasizing the importance of
associated signaling cascades in establishment of a func-
tional neuronal network. Although direct proof for require-
ment of the human WAVE/SCAR complex in establishment
of a properly wired nervous system is missing at present,
functional studies on single subunits of the complex in
Drosophila have provided compelling evidence for their
importance in development of the nervous system (Bogdan
and Klambt, 2003; Hummel et al., 2000; Schenck et al.,
2003; Zallen et al., 2002). Finally, it was recently shown that
one of the SCAR-associated proteins, CYFIP, links dRac1
signaling to dFMR1, the fly ortholog of the Fragile X
Mental Retardation Protein (FMRP) (Schenck et al., 2001,
2003). FMRP is thought to act as a regulator of translation
required in synapse formation, learning and memory
(Bardoni and Mandel, 2002; Willemsen et al., 2004). This
suggested the possibility that the WAVE/SCAR complex
coordinates several molecular and functional pathways.
By using the fly animal model, we here show that the
WAVE/SCAR complex is an evolutionarily conserved multi-
functional unit that controls and thereby coordinates specific
aspects of axonal development and synapse morphology.
Mutation in any one of three examined WAVE/SCAR
complex components—SCAR, CYFIP or Kette—leads to
instability of its partners and must be therefore considered as
a multiple mutation. Thus, the common axonal and synaptic
phenotypes observed in the single SCAR, CYFIP and Kette
mutations are due to disruption of the signaling cascades
associated with the three proteins. Furthermore, our data on a
developing organism support the view that WAVE/SCAR
complex function is controlled at the level of proteinstability, subcellular localisation and possibly post-transla-
tional modification.Materials and methods
Genetics
The wild-type strain was Sevelen. The utilised mutant
strains were SCARD37, SCARK13811, CYFIPD85.1, and Kette
alleles Kette03335, KetteGI-37, KetteJI-70, and KetteD2-6. Elav-
gal4 and Kette03335 strains were obtained from the Berkeley
stock centre; other Kette mutants and a UAS-Kette trans-
genic strain were kindly provided by C. Kl7mbt. For the
rescue, we recombined UAS-Kette onto the KetteJI-70
chromosome. The used UAS-SCAR and UAS-CYFIP trans-
genic strains were UAS-SCAR#3 and UAS-CYFIP13.2, the
latter one kindly provided by N. Harden. Blue balancers
were used to identify homozygous mutant embryos. CyO
GFP and TM6 Tb balancers allowed identification of
homozygous mutant larvae.
In situ hybridisation and immunolabeling
In situ hybridisation using digoxigenin-labeled riboprobes
and immunolabeling on whole-mount embryos were per-
formed according to standard procedures. CYFIP, Kette and
SCAR riboprobes were generated from full-length cDNAs.
Polyclonal Kette antibody #2081 was raised in rabbit against
peptide RHNDNPPLLKNKGC. Anti-Kette was affinity
purified using the same peptide on Sulfolink Coupling Gel
columns (Pierce) and was used at 1:100. Other antibodies
used in immunolabeling were anti-Fas II (1:50) (gift of C.
Goodman), anti-h-gal (1:500) (Sigma, Cappel), anti-SCAR
(gift of J. Zallen) and anti-CYFIP #1719 at 1:100. Secondary
antibodies coupled with Cy3 or FITC (Jackson) were used at
1:400. For evaluation of NMJs, larvae open-book prepara-
tions were performed as described in Bellen and Budnik
(2000), and immunolabeled with anti-DLG (1:20) (DSHB).
At least 10 animals were analysed per genotype. Pictures of
synapses were imported in the in-house developed TCS/timt
software that quantified synaptic length by automatic
measurement of redrawn synaptic terminals. Statistical
significance was calculated using ANOVA and the New-
man–Keuls Method for post hoc pairwise analyses. Larvae of
examined genotypes were all of normal body size.
Immunoprecipitations
S2 cells were cultured in Schneider cell medium (Gibco
BRL) + 10% fetal calf serum. Cytoplasmic extracts were
prepared by lysing S2 cells in buffer [300 mM NaCl, 20 mM
Tris–HCl pH 7.5, 5 mM MgCl2, 0,4% Triton X-100,
protease inhibitor cocktail (PIC)], kept on ice for 10 min.
The supernatant of a 2000  g centrifugation was
recovered. Aliquots were incubated for 6 h with 4 Ag of
A. Schenck et al. / Developmental Biology 274 (2004) 260–270262either anti-CYFIP #1719 or rabbit IgG and protein A
Sepharose. Beads were extensively washed in lysis buffer,
directly boiled in SDS-PAGE loading buffer and part of the
reaction was subjected to SDS-PAGE analysis.
Embryonic extracts
For extracts of homozygous mutant embryos, overnight
(18 h) cages of the heterozygous mutant strains carrying blue
balancer chromosomes were harvested and embryos were
subjected to X-gal staining without fixation step. Wild-type
embryos were subjected to the same procedure. Late-stage
embryos (stage 12–17; according to Campos-Ortega and
Hartenstein, 1985) lacking X-gal staining were hand-selected
and counted, transferred into an Eppendorf tube and mashed
with a pestle in (150 mM NaCl, 20 mM Tris–HCl pH 7.5, 1
mM EDTA, 0,1 mM MgCl2, 1% Triton X-100, PIC),
followed by an incubation on ice for 10 min. The supernatant
of a 12,000 g centrifugation was briefly sonicated, and the
amount of total protein was determined by Bradford assay.
Western blot analysis
Proteins were separated in 7% polyacrylamide gels. SDS-
PAGE and blotting were performed according to standard
procedures. Primary antibodies used in Western blot
analysis were anti-CYFIP #1719 (1:200), anti-SCAR
(1:1500), anti-Kette #2081 and anti-h-tubulin (1:4000)
(Chemicon). HRP-conjugated secondary antibodies (Jack-
son) were used at 1:5000.
Microscopy
The confocal microscope was a Leica TCS-SP1. Con-
focal images were assembled using an in-house developed
software. Synapse images were obtained using a Zeiss
Axiophot2 microscope.
Supplemental data
A supplemental table shows quantitative analysis of
central axon defects observed in SCARD37, CYFIPD85.1, and
Kette03335 homozygous mutant embryos, as depicted in Fig.
2. A supplemental figure allows direct comparison between
endogenous and overexpressed SCAR protein in an
immunolabeling experiment.
Fig. 1. Drosophila proteins CYFIP, Kette and SCAR co-localise and form a
complex in vivo. (A) Co-immunoprecipitation experiments of CYFIP, Kette
and SCAR proteins from Drosophila S2 cytoplasmic cell extract
demonstrate physical association of the endogenous proteins. Lanes, from
left to right: anti-CYFIP immunoprecipitation, IgG control immunopreci-
pitation, input (cytoplasmic extract). Proteins are indicated on the right;
their molecular weights are indicated on the left. Note the doublet revealed
by anti-SCAR antibody. (B) Localisation of endogenous CYFIP, Kette and
SCAR proteins in embryogenesis. Antibodies used are indicated on the left.
Embryos at stage 14–16, lateral views. Images are projections of few
confocal section near the midline. Commissural labeling is observed. Scale
bar: 50 Am.Results
The Drosophila proteins CYFIP, SCAR and Kette form a
complex
To provide formal evidence that the Drosophila SCAR,
CYFIP and Kette proteins form a complex, we performed
co-immunoprecipitation experiments from cytoplasmicextracts of Drosophila Schneider (S2) cells using antibodies
raised against CYFIP (Schenck et al., 2003). Extract and co-
immunoprecipitated material were subjected to Western blot
analysis using antibodies against SCAR (Zallen et al., 2002)
and Kette (see Materials and methods), the fly orthologs of
WAVE and Hem-2/NAP125, respectively, which both
associate with the human CYFIP2 protein (Eden et al.,
2002). Anti-Kette antibody reveals a band of 112 kDa (Fig.
1A, right lane), whereas anti-SCAR reveals a doublet of
about 66 and 70 kDa (Fig. 1A, right lane), one band of
which may represent a post-translationally modified SCAR
protein. Further evidence for antibody specificity is pre-
sented below (see Fig. 3B). The two Drosophila proteins are
found to specifically co-immunoprecipitate with CYFIP
(Fig. 1A, left lane). Neither Kette nor SCAR proteins are
detected in a control experiment using rabbit IgG for
precipitation (Fig. 1A, middle lane).
Using the same antibodies, we found that, in wild-type
embryos, Kette is present in longitudinal connectives as well
as commissures during establishment of the axonal network
(Fig. 1B), like SCAR and CYFIP (Fig. 1B and Schenck et
al., 2003; Zallen et al., 2002). By late stages, all three
proteins accumulate in longitudinal connectives (see Fig. 3,
wt panels), strongly suggesting that they act as a physical
and functional unit during embryogenesis. In summary, the
WAVE/SCAR complex is conserved in Drosophila and its
members accumulate in axons of the nervous system.
The WAVE/SCAR complex regulates axon pathfinding and
motor nerve branching
We recently demonstrated that CYFIP loss results in
axon pathfinding defects at the ventral midline and in
A. Schenck et al. / Developmental Biology 274 (2004) 260–270 263ectopic motor nerve branching (Schenck et al., 2003). The
pleiotropic defects within and outside the nervous system
previously reported in zygotic Kette null embryos (Hummel
et al., 2000) and in embryos devoid of maternal and zygotic
SCAR (Zallen et al., 2002) make it difficult to pinpoint the
cause of their axonal phenotypes, which prompted us to
score for defects in milder mutant conditions. Immunolab-
eling with anti-FasII, which specifically recognises three
longitudinal fascicles and motor axons (Figs. 2A,H), revealsFig. 2. Axonal phenotypes of CYFIP, SCAR and Kette mutant embryos. All pane
anti-FasII. Genotypes are indicated to the top. (A–G) Central axon tracts, anterior
Arrowheads label intersegmental nerves (ISN) of two abdominal segments. Arro
CYFIP, SCAR and Kette mutants, respectively. Panels E–G showing severe pheno
Asterisks indicate ectopic ISN branching (panels I–K). Scale bar: 20 Am.prominent axon defects in hypomorphic Kette embryos (P-
insertion Kette03335) with overall wild-type morphology and
intact somatic musculature (data not shown). These defects
include ectopic midline crossing (Figs. 2D,G) and motor
nerve branching (Fig. 2K) of variable severity, which
strongly resemble those displayed by CYFIPD85.1 embryos
(Figs. 2B,E,I; Schenck et al., 2003). Albeit at lower
frequencies, three weak hypomorphic Kette alleles, Ket-
teGI-37, KetteJI-70 and KetteD2-6 (Hummel et al., 2000) showls show homozygous embryos of stage 16–17, labeled by neuronal marker
on top. (H–K) Peripheral motor nerves, dorsal to the top, anterior to the left.
ws in panels B–D indicate axon guidance defects at the ventral midline in
types observed in the same mutant lines, which illustrates defect variability.
A. Schenck et al. / Developmental Biology 274 (2004) 260–270264the same phenotypes (data not shown), indicating that they
are specifically due to loss of Kette activity.
The same type and variability of defects are also observed
in SCARD37 (zygotic) null embryos (Figs. 2C,F,J) that appear
rather normal using the more general central axon marker
BP102 (Bogdan and Klambt, 2003; Zallen et al., 2002 and
data not shown). SCARk13811, a weak hypomorph, only
shows occasional defects (data not shown). A quantitative
analysis of central axon defects inCYFIPD85.1,Kette03335 and
SCARD37 mutants is available as Supplemental Data.
In conclusion, biochemical and genetic data show that
Kette and SCAR are implicated in establishment of the same
axon pathways in the nervous system.
Mutations in any of the three genes (SCAR, Kette and
CYFIP) result in loss of the remaining complex components
In Hela, Dictyostelium and Drosophila cellular systems,
it was recently reported that knockdown of either CYFIP
(alias PirA, Sra1) or Kette causes SCAR protein instability
(Blagg et al., 2003; Kunda et al., 2003; Rogers et al., 2003;
Steffen et al., 2004). In agreement, SCAR axonal labeling is
dramatically reduced in both CYFIPD85.1 and Kette03335Fig. 3. CYFIP, Kette and SCAR protein pattern in CYFIP, Kette, SCAR mutant e
mutant genotypes (top). Antibodies are indicated to the left. All panels show vent
patterns (Fig. 1) have been added for convenience. Whereas residual labeling in C
two proteins, Kette amounts in Kette03335 embryos are below the detection leve
Western blotting. Extracts are from wt and homozygous mutant embryos stage 12–
dramatic loss of the remaining complex components. Scale bar: 50 Am.embryos compared to its wild-type pattern. Strikingly, we
observed that the converse is also true; that is, CYFIP
axonal labeling is completely missing in both SCARD37 and
Kette03335 embryos and Kette axonal labeling is absent in
SCARD37 and CYFIPD85.1 embryos (Fig. 3A). In all cases,
axonal protein patterns are disrupted throughout embryo-
genesis (data not shown).
To corroborate that defective axonal labeling in mutants
is a consequence of protein loss, not mislocalisation, we
performed a quantitative Western blot analysis using
extracts of wild-type and homozygous mutant late-stage
embryos (see Materials and methods). CYFIP and Kette
proteins are indeed undetectable in SCAR, CYFIP and Kette
embryonic mutant extracts. In agreement with immunolab-
eling results, extracts contain residual levels (3–9%) of the
SCAR protein (Fig. 3B). These data demonstrate for the first
time that levels of any of the three proteins, SCAR, CYFIP
and Kette, depend on the presence of its complex partners.
To determine the cause of such SCAR, CYFIP and Kette
protein loss, we performed whole mount in situ hybrid-
isation using probes specific for each of the three genes on
wild-type and mutant embryos. These experiments unequiv-
ocally demonstrate that the mRNA levels of any one of thembryos. (A) Whole-mount immunohistochemistry on embryos of indicated
ral views of stage 16/17 embryos, anterior to the left. Wild-type expression
YFIPD85.1 and SCARD37 mutants highlights the maternal contribution of the
l. (B) Quantitative analysis of CYFIP, Kette and SCAR protein levels by
17, genotypes as above. (A, B) Note that mutations in any gene also result in
Fig. 4. CYFIP, Kette and SCAR mRNA pattern in wild-type and in CYFIP, Kette, SCAR mutant embryos. In situ hybridisation using CYFIP, Kette or SCAR
specific probes on wild-type and mutant embryos (genotypes). Mutations in CYFIP, Kette or SCAR have no effect on mRNA levels of the remaining complex
components. Scale bar: 50 Am.
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in any other component of the complex (Fig. 4). Hence, the
observed loss of CYFIP, Kette and SCAR proteins (Fig. 3)
is not due to transcriptional defects. The fact that, in mutant
conditions, all three complex components are targeted to
degradation pinpoints an additional level of control, which
may regulate signaling in addition to the proposed
regulation by complex dissociation (Eden et al., 2002) or
localisation (Bogdan and Klambt, 2003; Innocenti et al.,
2004; Kunda et al., 2003; Steffen et al., 2004).
Multiple levels of WAVE/SCAR complex regulation in vivo
Because it appears not possible to target single compo-
nents of the WAVE/SCAR complex by loss of function
conditions for the above-mentioned reasons, we wondered
whether gain of function studies could help to allocate
specific roles. For this purpose, we separately overexpressed
SCAR, CYFIP or Kette using the elav-gal4 panneuronal
driver. Surprisingly, while recombinant WAVE/SCAR pro-
tein is constitutively active in vitro (Eden et al., 2002;
Innocenti et al., 2004), in vivo SCAR, as well as CYFIP or
Kette overexpression does not cause any gain of function
phenotype and flies are perfectly viable (Fig. 5, bottomFig. 5. CYFIP, Kette and SCAR gain of function phenotypes. In vivo overexpre
Genotypes on top. Overexpressed protein is detected by the respective antibody, a
marker FasII, which reveals wild-type morphology. Note that overexpressed CYF
SCAR protein is also detected at central axons (arrows). For a direct comparison
Data. Scale bar: 50 Am.panels, data not shown, previously described for Kette;
Bogdan and Klambt, 2003). Lack of overexpression
phenotypes is not due to protein degradation, because
protein levels are strongly increased compared to those
observed in wild-type embryos, as measured by Western
blot analysis (data not shown) and immunolabeling experi-
ments (Fig. 5 and Supplemental Data).
Interestingly, in addition to central axon labeling also
detected in wild-type embryos, very strong labeling of
overexpressed CYFIP and Kette is detected in neuronal cell
bodies of the ventral cord (Fig. 5). The fact that excess
CYFIP and Kette proteins fail to localize at central axons
suggests a need for active transport. Cell body accumulation
of CYFIP and Kette is likely not due to titration of the
transport machinery because overexpressed SCAR protein
does succeed in accumulating at central axons (Fig. 5, see
arrows and Supplemental Data). It is then intriguing to note
that overexpressed SCAR, which does reach its normal
destination and is thought to be in the active state on its own
(Blagg and Insall, 2004; Eden et al., 2002; Innocenti et al.,
2004), still does not disturb wiring of the nervous system.
Thus, while in vitro studies reveal the potential mode of
action of the SCAR protein, additional mechanisms must
exist, which control activity of the SCAR protein in vivo.ssion of CYFIP, Kette or SCAR using the panneuronal driver elav-gal4.
s indicated in top panels. Bottom panels show the same embryos labeled by
IP and Kette proteins accumulate in neuronal cell bodies, whereas excess
between endogenous and overexpressed SCAR protein, see Supplemental
A. Schenck et al. / Developmental Biology 274 (2004) 260–270266Kette and SCAR, like CYFIP, regulate synaptic morphology
at the neuromuscular junction
One of the WAVE/SCAR complex components, CYFIP,
genetically and biochemically interacts with the FMRP fly
ortholog dFMR1. Interestingly, dFMR1 is dispensable forFig. 6. Synaptic phenotypes of CYFIP, Kette or SCAR mutants. (A) DLG immun
instar larvae of the following genotypes are shown: wt, CYFIPD85.1, KetteJI-70/Ket
undergrowth and supernumerary budding. Inset in the Kette panel shows a high m
Synapses of heterozygous SCAR mutants also show a growth defect. Scale bar: 2
displayed by CYFIP, Kette or SCAR mutants, and their respective rescue experim
CYFIP, CYFIPD85.1 (CYFIP rescue), KetteJI-70/KetteD2-6 (Kette), elav-gal4/+; U
gal4/+; SCARD37/UAS-SCAR (SCAR rescue). Sample size (number of muscle 4
significance was calculated using ANOVA and the Newman–Keuls method for pos
bars (*P V 0.025, ***P V 0.001). No asterisk on top of a bar indicates P N 0.05. Le
Materials and methods).development of embryonic central axons (data not shown),
but affects synapse morphology (Zhang et al., 2001), where
its function is counteracted by CYFIP (Schenck et al.,
2003). Indeed, loss of CYFIP or dFMR1 leads to under-
grown vs. overgrown synapses at the larval neuromuscular
junction (NMJ), the fly model currently used to studyolabeling of muscle 4 synaptic terminals. Representative synapses of third
teD2-6 and SCARD37/+. Compared to wt, CYFIP and Kette synapses display
agnification of the same synapse, arrowheads labeling supernumerary buds.
0 or 7.5 Am (inset). (B) Statistic evaluation of the NMJ growth phenotypes
ents (shaded bars). Genotypes: wt, CYFIPD85.1 (CYFIP), elav-gal4; UAS-
AS-Kette, KetteJI-70/KetteD2-6 (Kette rescue), SCARD37/+ (SCAR/+), elav-
junctions scored) was 32 per genotype. Error bars indicate SEM, statistical
t hoc pairwise analyses. Significant differences vs. wt are indicated on top of
ngth of synaptic terminals in Am, as measured using TCS/timt software (see
Table 1
Genetic interactions at the NMJ between proteins of the WAVE1/SCAR
complex and the Fragile X protein
Genotype Synaptic length F SEM (Am)
Wild type (+) 111.1 F 3.3a
CYFIP/+ 93.4 F 2.3b P+ b 0.05
Kette/+ 91.9 F 4.1 P+ b 0.05
SCAR/+ 96.5 F 4.6a P+ b 0.05
SCAR/+; Kette/+ 90.1 F 4.1 P+ b 0.05
dFMR1/+ 119.8 F 5.1
dFMR1/CYFIP 100.2 F 4.9 PdFMR1/+ b 0.05
dFMR1/Kette 103.8 F 3.9 PdFMR1/+ b 0.05
SCAR/+; dFMR1/+ 104.4 F 4.4 PdFMR1/+ b 0.05
UAS-dFMR1 70.0 F 3.6b
UAS-dFMR1/UAS-CYFIP 88.7 F 4.1b PUAS-dFMR1 b 0.05
UAS-dFMR1/UAS-Kette 72.5 F 2.9 n.s.
UAS-dFMR1/UAS-SCAR 73.7 F 4.9 n.s.
CYFIP, Kette, and SCAR alleles as in Fig. 4. Overexpression of UAS
constructs was driven by elav-Gal4. Sample size per genotype was 28–32.
P values vs. indicated genotypes (superscript) are determined by ANOVA
and post hoc Newman–Keuls Test. n.s.: not significant (P N 0.05).
a See Fig. 6.
b See Schenck et al. (2003).
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CYFIP or Kette, lead to very similar axonal abnormalities,
we attempted to address whether the CYFIP synapse
phenotype (70.4 Am vs. 111.1 Am wild-type length, P b
0.001; Fig. 6; Schenck et al., 2003) is also shared.
SCAR and most Kette mutations are embryonic lethal
(Zallen et al., 2002), (Hummel et al., 2000), preventing us
from analyzing homozygous null larvae. However, the
hypomorphic KetteJ1-70 mutation gives rise to larval
escapers that indeed show undergrown synapses compared
to wt. Because synapse morphology is disturbed in CYFIP
(Schenck et al., 2003) and Kette mutants (this study), it is
not possible to count boutons, the parameter currently used
to evaluate synapses. We therefore used a computer-assisted
program that allows us to measure the overall length of the
synapse, a parameter that we have previously shown to
correlate well with bouton number (Schenck et al., 2003).
This quantitative evaluation revealed a highly significant
difference between KetteJ1-70 and wild-type synapses (85.8
Am vs. 111.1 Amwild-type length, P b 0.001). To exclude an
impact of genetic background on this phenotype, we also
scored synapses of larvae carrying the KetteJ1-70 chromo-
some in trans with the hypomorphic excision allele KetteD2-6
(Hummel et al., 2000). Synapses of these larvae are
significantly shortened as well (86.2 vs. 111.1 Am wild-type
length, P b 0.001, Fig. 6). Interestingly, synaptic terminals of
Kette mutants share the abnormally high number of
synaptic buds (Fig. 6A, inset) (5.1 vs. 1.6 buds per synapse,
P b 0.001) shown by homozygous CYFIP mutants (7.8
buds, P b 0.001) (Schenck et al., 2003). Because buds
arising from existing boutons have been described as an
intermediate structure toward establishment of a new bouton
(Zito et al., 1999), this phenotype likely reflects a defect in
synapse maturation. Most importantly, as previously shown
for CYFIP, Kette synaptic defects (length and bud number)
are rescued by transgenic expression of Kette (UAS-Kette)
in neurons (Fig. 6B; rescued animals: 2.3 buds). This
provides evidence for the specificity of the defects observed
in the hypomorph and indicates that such defects are of
presynaptic origin.
To determine whether SCAR mutations affect synapse
morphology, we took advantage of the observation that not
only homozygous but also heterozygous CYFIP mutants
exhibit a reduction in synaptic length (to 94.0 vs. 111.1 Am
wild-type length), suggestive of a dose-dependent effect
(Schenck et al., 2003). We thus analysed synapses of larvae
heterozygous for the SCARD37 null allele and found that
they are indeed significantly shorter than their wt counter-
parts (96.5 vs. 111.1 Am wild-type length, P V 0.05) (Figs.
6A,B), to an extent comparable to those of heterozygous
CYFIP animals. Like CYFIP/+ synapses (Schenck et al.,
2003), SCARD37/+ synapses do not show abnormal budding
(Fig. 6A) (2.3 buds per synapse). Finally, the length of
SCARD37/+ synaptic terminals is rescued by neuronal
SCAR expression (Fig. 6B). In summary, our data identify
the WAVE/SCAR complex as a crucial component requiredfor normal development of synapse morphology at the
neuromuscular junction.
Genetic interactions between the WAVE/SCAR complex
components and the fly Fragile X Mental Retardation
ortholog
To characterise the impact of WAVE/SCAR complex
signaling to the dFMR1 pathway, we performed genetic
interaction experiments at the NMJ using both loss and gain
of function conditions. As a prerequisite for these experi-
ments, we completed the evaluation of heterozygous mutant
phenotypes for the three WAVE/SCAR complex compo-
nents and dFMR1. Results are summarised in Table 1. In
brief, CYFIP, SCAR and Kette heterozygous synapses are
significantly undergrown, whereas dFMR1 heterozygous
synapses are significantly extended compared to wild-type
structures. Heterozygous combinations between dFMR1 and
any one of CYFIP, SCAR or Kette genes suppresses the
dFMR1 overgrowth phenotype, which suggests an antago-
nistic relationship between the WAVE/SCAR complex and
dFMR1. In clear contrast, synapse undergrowth defect
caused by overexpression of dFMR1 (Schenck et al.,
2003; Zhang et al., 2001) is suppressed by co-overexpres-
sion of CYFIP but, notably, not by co-overexpression of
Kette or SCAR (Table 1 and Schenck et al., 2003).
Thus, while CYFIP and dFMR1 show genetic interaction
in both loss and gain of function experiments, Kette or
SCAR interact with dFMR1 only in loss but not in gain of
function experiments. This demonstrates that Kette and
SCAR cannot directly antagonise dFMR1 function. Genetic
conditions that reduce their levels will, however, necessarily
affect levels of their partner CYFIP, which, as previously
demonstrated, can directly antagonise dFMR1-dependent
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Zhang et al., 2001).
Finally, we found that Kette synapse undergrowth is not
modified by reduced levels of SCAR (Table 1), even though
heterozygous SCAR mutants already show reduced synaptic
length. This is in line with our view that, in conditions of
reduced levels of two or more complex components, the
most limiting of them determines the amount of its partners
and thus the degree of synapse phenotype.Discussion
The mammalian WAVE/SCAR complex is recently
shown to be an integral part of Rac1 GTPase signaling
pathways that coordinate actin cytoskeleton remodeling.
Although mutations in single components call for a role of
these proteins in construction of the nervous system
(Bogdan and Klambt, 2003; Hummel et al., 2000; Schenck
et al., 2003; Zallen et al., 2002), little is known about
regulation and function of the WAVE/SCAR complex in this
tissue. In this study, we provide evidence that the three
Drosophila proteins, SCAR, CYFIP and Kette, co-localise
during embryogenesis, form a complex in vivo and that they
are submitted to interdependent, posttranscriptional, control.
Moreover, we show that the WAVE/SCAR complex acts as
a functional unit coordinating different aspects of axonal
and synapse development, revealing its role in core signal-
ing pathways underlying neuronal connectivity.
The WAVE/SCAR complex—a multifunctional unit
The analysis of CYFIP, SCAR and Kette mutant
phenotypes and their genetic interaction with dFMR1 call
for distinct pathways being triggered by the WAVE/SCAR
unit. Better understanding of specific contribution requires a
more complete knowledge on these signaling pathways.
First conclusions, however, can be drawn. Guidance of
embryonic central axons is, for example, affected in WAVE/
SCAR complex but not in dFMR1 mutants and is hence
controlled by dFMR1-independent pathways downstream of
the WAVE/SCAR complex. In fact, central axons may be
under control of the SCAR-Arp2/3 pathway, because
mutations in different subunits of the Arp2/3 complex result
in disruption of these axon tracts (Zallen et al., 2002).
In contrast, dFMR1 as well as WAVE/SCAR complex
mutants affect NMJ morphology (Zhang et al., 2001),
suggesting a role of one or more complex components in
this process. Indeed, overexpressed CYFIP rescues the
dFMR1 gain of function phenotype, while overexpressed
Kette and SCAR do not. This indicates that only CYFIP can
signal to dFMR1 and suggests that the Kette and SCAR
synaptic phenotypes are indirect consequences of CYFIP
protein degradation. The fact that nevertheless, CYFIP,
Kette or SCAR mutations compensate for the dFMR1 loss of
function phenotype further supports the view that theWAVE/SCAR complex acts as an integral unit. While these
studies do not exclude a direct role of WAVE/SCAR-
mediated Arp2/3-dependent actin nucleation in synapse
morphology, they clearly highlight the importance of CYFIP
signaling to dFMR1. Interestingly, it has been recently
shown that WASP, the second actin nucleation promoting
factor, as well as its interacting protein Nervous wreck,
control NMJ morphology (Coyle et al., 2004). WASP is also
directly linked to the WAVE/SCAR complex by its
interaction with the Abi protein (Bogdan and Klambt,
2003), indicating that proper synapse morphology requires
integration of several related signaling pathways. Under-
standing the molecular bases of neuronal connectivity
clearly implies evaluation of the specific contribution and
integration of Arp2/3 and Fragile X Mental Retardation
Protein mediated pathways at the synapse.
CYFIP, SCAR and Kette are interdependent members of the
fly WAVE/SCAR complex
Two recent studies on fly and vertebrate cell cultures
have shown that overexpressed SCAR or WAVE2 in cells
that were knocked down for other components of the
complex fail to be recruited to the cell periphery and do not
rescue cytoskeletal defects (Kunda et al., 2003; Steffen et
al., 2004). Our loss and gain of function data show that
WAVE/SCAR complex function relies on the integrity of all
its components and that not only SCAR, but also its partners
require proper control of protein stability and localisation.
Surprisingly, the overexpressed SCAR protein can still
accumulate, at least in part, at central axons, whereas excess
CYFIP and Kette proteins cannot, suggesting the possibility
that SCAR is directly connected to the translocation
machinery responsible for axonal recruitment of the
WAVE/SCAR complex.
Our observation, that even upon simultaneous over-
expression in pairwise or triple combinations SCAR is
found in axons whereas excess CYFIP and Kette are not
(data not shown), is explained by the recent finding that
CYFIP and Kette do not bind SCAR directly (Gautreau et
al., 2004; Innocenti et al., 2004) and must hence fail to
travel piggybaggy with SCAR.
Even properly localised excess of SCAR, however, is not
capable of inducing an aberrant phenotype. Localisation of
SCAR is hence a prerequisite but not sufficient to activate
Arp2/3-dependent changes in the actin cytoskeleton, calling
for an additional level of SCAR activity control. Whether
this control occurs through phosphorylation, as in the case
of the WAVE/SCAR related protein WASP (Torres and
Rosen, 2003) (Cory et al., 2003) and as suggested by the
doublet revealed by anti-SCAR in immunoblotting (Fig. 1),
remains to be determined.
Direct comparison of axonal and synaptic phenotypes
displayed by CYFIP, Kette and SCAR mutant alleles has
revealed that they are undistinguishable, a finding that
suggested a common pathogenic mechanism. Indeed, we
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SCAR is subjected to protein turnover if either CYFIP or
Kette are missing, as predictable from studies in cellular
systems (Blagg et al., 2003; Kunda et al., 2003; Rogers et al.,
2003; Steffen et al., 2004), but also CYFIP and Kette are lost
if one of their partners is absent. These results demonstrate for
the first time that not only SCAR levels are regulated by
CYFIP and Kette dose, but also CYFIP and Kette levels
depend on the dose of their protein partners. Thus, instead of
being considered as single mutants, CYFIP, Kette and SCAR
mutants have unambiguously to be judged as defective in
multiple components of the WAVE/SCAR complex. This
common biochemical basis (i.e., lack of all three proteins)
clearly accounts for the identical observed phenotypes in the
loss of function conditions, regardless of any effect these
proteins may exert on each other in this tissue.
An important question that has remained so far unan-
swered by studies on the WAVE/SCAR complex is why
WAVE/SCAR requires four associated proteins to transduce
Rac1 signaling to the Arp2/3 complex, whereas the WAVE/
SCAR-related protein WASP is capable of doing this job on
its own (see Blagg and Insall, 2004 for an overview). We
speculate that the hetreopentameric WAVE/SCAR complex
constitutes a checkpoint for a multitude of signaling
pathways, which ensures their simultaneous activation.
Several hints exist now in the literature indicating additional
functions of Kette, Abi and CYFIP proteins. Whereas the
functional significance of Kette interaction with signaling
proteins like dynamin and Eps8 (Tsuboi et al., 2002) and
Abi interaction with the Abl nonreceptor tyrosin kinase (Dai
and Pendergast, 1995; Shi et al., 1995) remain to be
validated, our work has delineated a first pathway specific to
one of the WAVE/SCAR-associated proteins, CYFIP signal-
ing to dFMR1.
In the midst of mental retardation genes—the WAVE/SCAR
complex and the molecular basis of cognition
Our data show that integrity of the WAVE/SCAR
complex plays a pivotal function in nervous system
development and that CYFIP and Kette do not simply
function as SCAR silencers or proteins merely stabilising/
localizing SCAR. This is of particular interest if one
considers that a series of genes connected to the WAVE/
SCAR complex and its associated signaling pathways are
implicated in human mental retardation. First, several
mutations directly affecting Rho/Rac regulatory or effector
proteins cause X-linked mental retardation (reviewed in
Chelly and Mandel, 2001; Ramakers, 2002). Moreover, the
most frequent cause of hereditary mental retardation is due
to mutations in the Fragile X Mental Retardation gene,
which is connected to Rac1 via CYFIP (Billuart and Chelly,
2003; Schenck et al., 2003) and thereby to the WAVE/
SCAR complex (present study). Finally, MEGAP (mental
disorder-associated GAP protein), also known as WRP or
srGAP3, encoded by one of the few so far identifiedautosomal mental retardation genes (Endris et al., 2002), is
directly linked to the WAVE/SCAR complex. Indeed,
MEGAP/WRP/srGAP3 is a negative regulator of the Rac1
GTPase and binds directly to WAVE1, suggesting that the
protein terminates Rac1 signaling to the complex (Soderling
et al., 2002). The WAVE/SCAR complex is thus central to
signaling pathways mutated in impaired conditions of
neuronal functioning.
In light of the data obtained in fly, one can speculate that
also (some of) the different human genetic conditions
mentioned above may have a common biochemical basis.
If it can be formally proven that, analogous to flies, also the
recently reported WAVE1 knockout mouse, notably char-
acterised by cognitive deficits (Soderling et al., 2003), is
devoid of CYFIP and Kette proteins, this would provide the
first direct evidence for the implication of this complex not
only in neuronal connectivity but also in cognitive function.
Dissecting the WAVE/SCAR complex-dependent path-
ways and understanding the role of such pathways in local
actin cytoskeleton remodeling constitute challenging ques-
tions in the field of neuronal plasticity and cognitive
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